Hospital-based evidence on cost-effectiveness of brucellosis diagnostic tests and treatment in Kenyan hospitals

Hospitals in Kenya continue to use the Febrile Antigen Brucella Agglutination Test (FBAT) to diagnose brucellosis, despite reports showing its inadequacy. This study generated hospital-based evidence on the performance and cost-effectiveness of the FBAT, compared to the Rose Bengal Test (RBT).Twelve...

Descripción completa

Detalles Bibliográficos
Autores principales: Alumasa, Lorren, Thomas, Lian F., Amanya, Fredrick, Njoroge, Samuel M., Moriyón, Ignacio, Makhandia, Josiah, Rushton, Jonathan, Fèvre, Eric M., Falzon, Laura C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833147/
https://www.ncbi.nlm.nih.gov/pubmed/33411798
http://dx.doi.org/10.1371/journal.pntd.0008977

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833147/
https://www.ncbi.nlm.nih.gov/pubmed/33411798
http://dx.doi.org/10.1371/journal.pntd.0008977

Ejemplares similares